| 7/20/2021 |
VitalConnect Announces Vista Solution Coverage from Aetna Health Care |
Business Wire |
SAN JOSE, Calif.--(BUSINESS WIRE)--Jul 20, 2021-- VitalConnect ®, Inc. , a leader in remote and in-hospital wearable biosensor technology , today announced that its product portfolio is now being covered by Aetna, a CVS Health company and one of the nation’s leading diversified health care benefits companies. This means that VitalConnect’s unique four-in-one cardiac monitoring solution for mobile cardiac telemetry, extended Holter, Holter, and cardiac ... |
| 4/22/2021 |
Implantable biosensors for healthcare | Did You Know? Implan… |
flickr.com |
... bio-Micro Electron Mechanical System (MEMS) and are emerging as potential non-invasive approach to detect and monitor biomarkers. Biosensors are clinically being used for the early detection of diabetes, cardiovascular diseases and cancers. Biosensor technology has huge applicability for the early detection of cancer which can increase patient survival and quality of life. Affymetrix a commercially available biosensors is widely used for early detection of cancer. But technological advances ... |
| 4/15/2021 |
Under-skin Microchip for Covid. Pentagon's Iniectable Hydrogel almost Ready! |
veteranstoday.com |
... Äôs Institute for Global Health Sciences.THE PROFUSA PROJECT BETWEEN 2012 AND 2016¬´The Defense Advanced Research Projects Agency (DARPA) has invested $7.5 million dollars in Profusa‚Äôs system of tissue-integrated, long-term biosensor technology that transmits a stream of metabolic chemistry data for up to two years. The technology is part of a paradigm shift from point-in-time blood test panels to continuous monitoring, said Profusa CEO ... |
| 4/15/2021 |
Under-skin Microchip for Covid. Pentagon's Iniectable Hydrogel almost Ready! |
therussophile.org |
... Äôs Institute for Global Health Sciences.THE PROFUSA PROJECT BETWEEN 2012 AND 2016¬´The Defense Advanced Research Projects Agency (DARPA) has invested $7.5 million dollars in Profusa‚Äôs system of tissue-integrated, long-term biosensor technology that transmits a stream of metabolic chemistry data for up to two years. The technology is part of a paradigm shift from point-in-time blood test panels to continuous monitoring, said Profusa CEO ... |
| 4/13/2021 |
Yale snags sponsored research deal with CYduct Diagnostics |
techtransfercentral.com |
... research deal with CYduct Diagnostics By David SchwartzPublished: April 13th, 2021Yale University has entered into a Sponsored Research Agreement CYduct Diagnostics, Inc., to test and evaluate the performance of the university’s nanowire biosensor technology for detecting critical protein biomarkers associated with the progression of breast cancer. The one-year agreement also grants CYduct an exclusive option for an exclusive worldwide license in the field of use to the ... |
| 4/9/2021 |
Purdue Professor Focuses on Costly Cattle Disease |
insideindianabusiness.com |
... awarded more than $1 million in grants to further his research of bovine respiratory disease, which is one of the most common and costly diseases affecting beef cattle.Mohit Verma is working to develop biosensor technology that would help cattle producers better manage the disease and reduce the use of antibiotics.“Bovine respiratory disease is a complex syndrome with multiple infectious agents, including bacteria and viruses,” Verma said. “And ... |
| 4/5/2021 |
Other news to note 5, 05 |
BioWorld |
... and nasal swab specimens with RT-PCR performed within 17 minutes.Westport, Conn.-based Cyduct Diagnostics Inc. is teaming up with Yale University to test and assess the performance of the university’s nanowire biosensor technology for detecting critical protein biomarkers associated with breast cancer progression. The sponsored research agreement, effective April 1, 2021, also grants Cyduct an option to obtain an exclusive worldwide license in the field of use ... |
| 4/5/2021 |
WESTPORT, CT / ACCESSWIRE / April 5, 2021 / CYduct |
wapakdailynews.com |
WESTPORT, CT CYduct Diagnostics, Inc. (OTC PINK:CYDX) announced that it has entered into a Sponsored Research Agreement, effective April 1, 2021, with Yale University to test and evaluate the performance of the University's nanowire biosensor technology for detecting critical protein biomarkers associated with the progression of Breast Cancer. The Agreement, which contains a detailed Statement of Work to be performed during the one-year term, also grants CYductDX an ... |
| 4/5/2021 |
The Ridgway Record |
ridgwayrecord.com |
WESTPORT, CT CYduct Diagnostics, Inc. (OTC PINK:CYDX) announced that it has entered into a Sponsored Research Agreement, effective April 1, 2021, with Yale University to test and evaluate the performance of the University's nanowire biosensor technology for detecting critical protein biomarkers associated with the progression of Breast Cancer. The Agreement, which contains a detailed Statement of Work to be performed during the one-year term, also grants CYductDX an ... |
| 4/5/2021 |
CYduct Diagnostics, Inc. Enters Proteomic Research Agreement With Yale University |
otcmarkets.com |
WESTPORT, CT / ACCESSWIRE / April 5, 2021 / CYduct Diagnostics, Inc. (OTC PINK:CYDX) announced that it has entered into a Sponsored Research Agreement, effective April 1, 2021, with Yale University to test and evaluate the performance of the University's nanowire biosensor technology for detecting critical protein biomarkers associated with the progression of Breast Cancer. The Agreement, which contains a detailed Statement of Work to be performed during the one-year term ... |
| 3/28/2021 |
[ASAP] Expanding the Chemical Space of Succinate Dehydrogenase Inhibitors via the Carbon–Silicon Switch Strategy |
acs.org |
... the Chemical Space of Succinate Dehydrogenase Inhibitors via the Carbon–Silicon Switch Strategy Ge Wei Ge Wei Key Laboratory of Pesticide and Chemical Biology of Ministry of Education, International Joint Research Center for Intelligent Biosensor Technology and Health of Ministry of Science and Technology, Central China Normal University, Luoyu Road 152, Wuhan 430079, People’s Republic of China Ming-Wei Huang Ming-Wei Huang Key Laboratory of Pesticide and Chemical ... |
| 3/19/2021 |
[ASAP] Genetic Engineering and Chemical Control Related to Abscisic Acid for Improving Plant Drought Tolerance |
acs.org |
... Yang Guang-Fu Yang Key Laboratory of Pesticide & Chemical Biology, Ministry of Education, College of Chemistry, Central China Normal University, Wuhan, Hubei 430079, People’s Republic of China International Joint Research Center for Intelligent Biosensor Technology and Health, Central China Normal University, Wuhan, Hubei 430079, People’s Republic of China Collaborative Innovation Center of Chemical Science and Engineering, Tianjin 300072, People’s Republic of China Cite this: J. Agric. Food ... |
| 2/1/2021 |
Biosensor Applications |
loire-net.tv |
... detect analytes. These instruments have a wide range of applications ranging from clinical through to environmental and agricultural. The devices are also used in the food industry.Some examples of the fields that use biosensor technology include: General healthcare monitoring Clinical analysis and diagnosis of disease Veterinary and agricultural applications Industrial processing and monitoring Environmental pollution controlBiosensors can provide cost-effective, easy-to-use, sensitive and highly accurate detection ... |
| 1/11/2021 |
ACC.21 to offer remote COVID-19 screening |
cardiacrhythmnews.com |
... BioSticker and medical-grade BioButton wearable devices allow for continuous vital sign monitoring of temperature, heart rate and respiratory rate at rest to enable early detection of adverse vital sign trends through its proprietary biosensor technology and advanced analytics.In a statement, ACC said that its 2021 scientific session will bring together cardiologists and cardiovascular specialists from around the world to share the newest discoveries in treatment and prevention. ACC ... |
| 1/11/2021 |
BioIntelliSense collaborates with American College of Cardiology to Advance Remote Cardiac Care |
cardiology2.com |
... BioSticker and medical-grade BioButton wearable devices allow for continuous vital sign monitoring of temperature, heart rate and respiratory rate at rest to enable early detection of adverse vital sign trends through its proprietary biosensor technology and advanced analytics. The strategic collaboration will combine ACC’s clinical expertise in heart health with BioIntelliSense’s effortless user experience and multi-parameter monitoring to make remote cardiac care scalable, reliable, and cost ... |
| 1/11/2021 |
BioIntelliSense and the American College of Cardiology join forces to advance remote cardiac care |
dotmed.com |
... BioSticker and medical-grade BioButton wearable devices allow for continuous vital sign monitoring of temperature, heart rate and respiratory rate at rest to enable early detection of adverse vital sign trends through its proprietary biosensor technology and advanced analytics. The strategic collaboration will combine ACC's clinical expertise in heart health with BioIntelliSense's effortless user experience and multi-parameter monitoring to make remote cardiac care scalable, reliable, and cost effective.ACC ... |
| 1/4/2021 |
[ASAP] Structure-Guided Discovery of Silicon-Containing Subnanomolar Inhibitor of Hydroxyphenylpyruvate Dioxygenase as a Potential Herbicide |
acs.org |
... of Silicon-Containing Subnanomolar Inhibitor of Hydroxyphenylpyruvate Dioxygenase as a Potential Herbicide Ren-Yu Qu Ren-Yu Qu Key Laboratory of Pesticide & Chemical Biology of Ministry of Education, International Joint Research Center for Intelligent Biosensor Technology and Health, College of Chemistry, Central China Normal University, Wuhan 430079, P. R. China Jia-Xu Nan Jia-Xu Nan Key Laboratory of Pesticide & Chemical Biology of Ministry of Education, International Joint Research Center ... |
| 12/15/2020 |
BioIntelliSense BioButton‚Ñ¢ Named CES 2021 Best of Innovation Award Honoree |
Business Insider |
... cleared BioButton is a coin-sized, disposable medical wearable device for continuous monitoring of temperature, heart rate and respiratory rate at rest to enable early detection of adverse vital sign trends through its proprietary biosensor technology and advanced analytics. Its effortless user experience design and multi-parameter capability makes remote monitoring scalable, reliable and cost effective."We are extremely honored to be named Best of Innovation as a CES 2021 ... |
| 12/10/2020 |
New serological assay provides rapid, accurate testing for SARS-CoV-2 antibodies |
sciencedaily.com |
2 New serological assay provides rapid, accurate testing for SARS-CoV-2 antibodies Using optical biosensor technology , the test provides quantitative measurements of antibodies in blood plasma in less than 20 minutes Date: University of California - Santa Cruz Summary: Researchers have developed a novel serological assay for the detection of antibodies to SARS-CoV-2, the coronavirus that causes COVID-19. Researchers say the new method is as accurate as ... |
| 11/23/2020 |
VitalConnect Announces the Launch of VitalPatch® RTM, a First-of-its-kind Extended Holter Technology for Cardiac Monitoring |
Business Wire |
SAN JOSE, Calif.- VitalConnect ® , Inc., a leader in remote and in-hospital wearable biosensor technology , announced today it has launched its VitalPatch RTM cardiac monitoring solution for patients who require extended Holter monitoring. VitalPatch RTM monitors for 21 cardiac arrhythmias through a unique AI-based ECG analysis solution and captures data on four key vital signs, providing a more complete view of a patient’s condition. Patient data is ... |